Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox in non-transfusion-dependent thalassemia with iron overload (China Phase IV)
CTR20130863Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of deferasirox in Thalassaemia, sponsored by Novartis. Started Aug 2014; status: completed.
02
Drugs
deferasirox
03
Conditions
Thalassaemia
Beyond the preview
Go deeper on CTR20130863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130863.